US court dismisses Amgen biologic patent suit

28-03-2018

US court dismisses Amgen biologic patent suit

TheDesign / iStockphoto.com

A Delaware court has dismissed a patent infringement claim brought by Amgen against a biosimilar maker.


Amgen, patent, patent infringement, Coherus Biosciences, Neulasta, Biologics Price Competition and Innovation Act, biologics, biosimilars

LSIPR